ALX Oncology Inc.

NASDAQ: ALXO · Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 1:19 PM

ALX Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-134.85M -160.81M -123.48M -83.46M
Depreciation & Amortization
872K 836K 342K 51K
Stock-Based Compensation
27.09M 26.27M 23.84M 13.91M
Other Working Capital
-8.41M 7.84M 5.34M -7.32M
Other Non-Cash Items
-2.6M -4.96M 228K 5.42M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-12.43M 8.3M 9.85M -4.03M
Operating Cash Flow
-121.91M -130.36M -89.22M -68.1M
Capital Expenditures
-447K -1.27M -1.43M -4.92M
Cash Acquisitions
n/a n/a 233.99K n/a
Purchase of Investments
-107.41M -246.63M -376.79M n/a
Sales Maturities Of Investments
194.11M 292.56M 142.8M n/a
Other Investing Acitivies
n/a n/a -233.99K n/a
Investing Cash Flow
86.26M 44.66M -235.42M -4.92M
Debt Repayment
-827K -388K 9.61M -281K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 792K -655K n/a
Financial Cash Flow
30.82M 59.29M 9.86M 2.47M
Net Cash Flow
-4.84M -26.42M -314.78M -70.55M
Free Cash Flow
-122.36M -131.64M -90.65M -73.02M